drugset / Trial / NCT03263273

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

NCT03263273

Phase 2 Completed 270 enrolled Hovione Scientia Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy of once-daily application of 1% and 3% HY01 Topical Gel, as assessed by the change in inflammatory lesion count from baseline over the 12-week treatment period in patients with moderate-to-severe papulopustular rosacea.

Timeline

Start
2017-10-30
Primary completion
2019-03-01
Completion
2019-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minocycline Small molecule 1 % Topical
Comparator Minocycline Small molecule 3 % Topical

Indications